Phreesia's big move back in 2024? Renewing its contract with the CMS Innovation Center, securing a spot until 2029 to amp up patient activation in kidney care. This isn't just some footnote; it’s a lifeline for nearly 200,000 Medicare beneficiaries wrestling with chronic kidney disease (CKD). The focus here is clear: boost how patients engage with their healthcare using the Patient Activation Measure (PAM), which fundamentally shifts how we evaluate health outcomes based on actual patient experiences.
Breaking Down Phreesia's KCC Model Impact
The Kidney Care Choices Model (KCC) has been Phreesia's game changer since 2019, pushing for early intervention strategies that delay dialysis and promote home treatment options. In just its first year of evaluation, KCC has notched impressive stats: an average increase of 8.8 PAM points across various groups—with transplant patients seeing a hefty 12.8-point jump. That kind of improvement hints at cost reductions up to 8%, according to earlier studies.
KCC Metrics Showing Real Progress
- Home Dialysis Surge: A striking 20% uptick in home dialysis usage.
- Peritoneal Dialysis Rates: These also rose sharply between 8% and 26%.
- Surgical Waitlist Growth: The number of patients on transplant waitlists jumped by 15%.
This isn’t just good PR; it's tangible progress that blows previous initiatives out of the water. You got a model here that effectively doubles typical activation score improvements while getting more folks engaged than ever before. But what’s the kicker? You’ve got Dr. Hilary Hatch from Phreesia talking about these metrics like they’re setting the stage for future expansions into other areas—if this keeps building momentum, could we be looking at broader applications for PAM?
This might just be the start—"The year one outcomes from KCC are groundbreaking," says Alan Glaseroff, MD.
The evidence backing PAM stems from over 800 peer-reviewed studies—it’s not fluff. As activation rises, so does medication adherence and overall satisfaction with treatment plans. We’re talking real implications for clinical outcomes where improved self-management leads directly to better health results. Yet still, there’s chatter around whether these wins can translate into sustainable practices long-term or if it’s just another flash in the pan.
